REGENCY HEALTH SERVICES INC
10-Q/A, 1996-06-27
SKILLED NURSING CARE FACILITIES
Previous: CALDWELL & ORKIN FUNDS INC, 24F-2NT, 1996-06-27
Next: DEAN WITTER PACIFIC GROWTH FUND INC, NSAR-A, 1996-06-27






                                   FORM 10-Q/A

                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

(Mark One)

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

         For the quarterly period ended March 31, 1996

                                       OR

[  ]     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

         For the transition period from ________ to ___________

                         Commission file number: 1-11144


                          Regency Health Services, Inc.

State or other jurisdiction of                               (I.R.S. Employer
incorporation or organization                                Identification No.)

Delaware                                                     33-0210226

Regency Health Services, Inc.
2742 Dow Avenue
Tustin, California  92680
714-544-4443


         Indicate by check mark whether the registrant (1) has filed all reports
required  to be filed by  Section  13 or 15(d) of the  Securities  Exchange  Act
ofv1934  during the  preceding  12 months (or for such  shorter  period that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes ____ No X

         Indicate the number of shares  outstanding of each of the  registrant's
classes of common stock, as of the latest practicable date.

Title                                                        Outstanding

Common stock                                                 16,705,265



<PAGE>


Part I. Financial Information

Item 1. Financial Statements.
<TABLE>


                          REGENCY HEALTH SERVICES, INC.
                           CONSOLIDATED BALANCE SHEETS
                        (In thousands, except par value)

                                     ASSETS

<CAPTION>

                                                                                               March 31,      December 31,
                                                                                                1996             1995
                                                                                            -------------    -------------
                                                                                              (Unaudited)
<S>                                                                                      <C>       <C>    <C>       <C> 
CURRENT ASSETS:
        Cash and cash equivalents                                                         $       33,955   $      104,238
        Restricted cash                                                                            3,925                -
        Accounts receivable, net of allowances of $4,259 at
             March 31, 1996 and $3,757 at December 31, 1995                                       71,500           54,050
        Notes and other receivables                                                                1,736            2,182
        Deferred income taxes                                                                      5,447            5,447
        Assets held for sale                                                                       7,751            8,970
        Other current assets                                                                       8,286            6,396
                                                                                            -------------    -------------

                  Total current assets                                                           132,600          181,283
                                                                                            -------------    -------------

PROPERTY AND EQUIPMENT:
        Land                                                                                      21,249           21,249
        Buildings and improvements                                                                98,481           96,396
        Leasehold interest - other                                                                17,549           17,556
        Leasehold interest - related party                                                         2,075            2,075
        Equipment                                                                                 27,710           24,610
                                                                                            -------------    -------------

                                                                                                 167,064          161,886
        Less - accumulated depreciation and amortization                                         (36,965)         (34,679)
                                                                                            -------------    -------------

                  Total property and equipment                                                   130,099          127,207
                                                                                            -------------    -------------

OTHER ASSETS:
        Mortgage notes receivable, net of allowances of $950 at
             March 31, 1996 and $951 at December 31, 1995                                          4,929            5,163
        Goodwill, net of accumulated amortization of $1,207 at
             March 31, 1996 and $563 at December 31, 1995                                         59,515           13,621
        Other assets, net of accumulated amortization of $2,641 at
             March 31, 1996 and $2,206 at December 31, 1995                                       27,163           15,697
                                                                                            -------------    -------------

                  Total other assets                                                              91,607           34,481
                                                                                            -------------    -------------

                                                                                          $      354,306   $      342,971
                                                                                            =============    =============



                  The   accompanying   notes  are  an  integral  part  of  these
consolidated financial statements.

<PAGE>



                          REGENCY HEALTH SERVICES, INC.
                     CONSOLIDATED BALANCE SHEETS (Continued)
                        (In thousands, except par value)

                      LIABILITIES AND STOCKHOLDERS' EQUITY

<CAPTION>

                                                                                              March 31,      December 31,
                                                                                               1996            1995
                                                                                            ------------   -------------
                                                                                             (Unaudited)
<S>                                                                                      <C>       <C>  <C>        <C>    

CURRENT LIABILITIES:
        Current portion of long-term debt                                                 $       1,706  $        4,371
        Accounts payable                                                                         25,854          22,285
        Accrued expenses                                                                          5,330           5,946
        Accrued compensation                                                                     18,894          18,051
        Accrued workers' compensation                                                             4,653           5,377
        Deferred revenue                                                                          1,829           1,743
        Accrued interest                                                                          6,082           4,231
                                                                                            ------------   -------------

                 Total current liabilities                                                       64,348          62,004
LONG-TERM DEBT, NET OF CURRENT PORTION                                                          184,148         179,615
OTHER LIABILITIES AND NONCURRENT RESERVES                                                        12,938          13,017
DEFERRED INCOME TAXES                                                                             9,413           7,946
                                                                                            ------------   -------------

                 Total liabilities                                                              270,847         262,582
                                                                                            ------------   -------------

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY:
        Common stock,  $.01 par value;  authorized - 35,000  shares;  16,705 and
             16,670 shares issued and outstanding at March 31, 1996
             and December 31, 1995, respectively                                                    167             167
        Additional paid-in capital                                                               57,012          56,679
        Retained earnings                                                                        26,280          23,543
                                                                                            ------------   -------------

                 Total stockholders' equity                                                      83,459          80,389
                                                                                            ------------   -------------

                                                                                          $     354,306  $      342,971
                                                                                            ============   =============






                  The   accompanying   notes  are  an  integral  part  of  these
consolidated financial statements.
<PAGE>





                          REGENCY HEALTH SERVICES, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                    (in thousands, except per share amounts)

<CAPTION>

                                                                                             Three months ended
                                                                                                  March 31,
                                                                                  ------------------------------------------
                                                                                         1996                  1995
                                                                                         ----                  ----
                                                                                                 (Unaudited)


<S>                                                                            <C>             <C>   <C>               <C>    
           
           NET OPERATING REVENUE                                                $            129,962  $              97,548
                                                                                  -------------------   --------------------

           COSTS AND EXPENSES:
               Operating expenses                                                            106,967                 78,972
               Corporate general and administrative                                            5,126                  5,248
               Rent expense                                                                    5,607                  4,153
               Depreciation and amortization                                                   3,175                  2,286
               Interest expense                                                                4,327                  1,910
                                                                                  -------------------   --------------------

                   Total costs and expenses                                                  125,202                 92,569
                                                                                  -------------------   --------------------

           INCOME BEFORE PROVISION FOR INCOME TAXES                                            4,760                  4,979
           PROVISION FOR INCOME TAXES                                                          2,023                  1,892
                                                                                  -------------------   --------------------

           NET INCOME                                                           $              2,737  $               3,087
                                                                                  ===================   ====================


           INCOME PER COMMON SHARE:
                Primary                                                         $             0.16    $                0.19
                                                                                  ===================   ====================

                Fully diluted                                                   $             0.16    $                0.18
                                                                                  ===================   ====================

           WEIGHTED AVERAGE SHARES OF COMMON STOCK
               AND EQUIVALENTS:
                Primary                                                                       16,803                 16,587
                                                                                  ===================   ====================

                Fully diluted                                                                 20,755                 20,540
                                                                                  ===================   ====================




                    The  accompanying  notes  are  an  integral  part  of  these
consolidated financial statements.


</TABLE>

<PAGE>




                          REGENCY HEALTH SERVICES, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)



1.       Basis of Presentation

         The unaudited  consolidated financial statements and related notes have
been  prepared  pursuant  to the rules and  regulations  of the  Securities  and
Exchange Commission.  Accordingly,  certain information and footnote disclosures
normally included in financial  statements prepared in accordance with generally
accepted  accounting  principles  have  not  been  presented.  The  accompanying
unaudited  financial  statements and related notes should be read in conjunction
with the consolidated financial statements and related notes included in Regency
Health Services,  Inc.'s ("Regency" or the "Company") 1995 Annual Report on Form
10-K.

         In the opinion of the management of Regency,  all material  adjustments
necessary  to  present  fairly the  Company's  financial  condition,  results of
operations,  and changes in  financial  position  have been made.  All  material
intercompany  balances,  profits,  and transactions  have been  eliminated.  The
consolidated results of operations  presented are not necessarily  indicative of
the consolidated results for a full year.

         The  preparation of financial  statements in conformity  with generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that  affect the  reported  amounts of assets and  liabilities  and
disclosure of  contingent  assets and  liabilities  at the date of the financial
statements  and the  reported  amounts  of  revenues  and  expenses  during  the
reporting period. Actual results could differ from those estimates.

         Certain amounts in the 1995 financial statements have been reclassified
to conform to the 1996 presentation.

2.       Net Income per Share

         For the three months ended March 31, 1996 and 1995,  primary income per
share was calculated  based on the weighted  average number of common and common
equivalent  shares  outstanding  during the periods.  For the three months ended
March 31,  1996 and 1995,  fully  diluted  income  per  share  was  computed  as
described  above and  includes  the  issuance of common  shares upon the assumed
conversion of the Convertible  Subordinated Debentures.  Additionally,  interest
and  amortization of  underwriting  costs related to such debentures were added,
net of tax, to income for the purpose of  calculating  fully diluted  income per
share. Such amounts aggregated  $488,000 and $510,000 for the three months ended
March 31, 1996 and 1995, respectively.

3.       Acquisitions

         Effective February 1, 1996, the Company acquired leasehold interests in
18 health care  facilities in Tennessee and North  Carolina with 2,375 beds from
Liberty Healthcare Limited Partnership ("Liberty") through an asset purchase for
$39.3  million  cash and a note  payable  for $2.2  million.  The  Company  also
acquired  Executive Pharmacy with a $763,000 note payable and an enteral feeding
business for $1.5 million  cash from  businesses  affiliated  with  Liberty.  In
addition, the Company paid $400,000 cash for the inventory of Liberty. A portion
of the  purchase  was funded  with notes  payable  may be reduced as a result of
certain seller liabilities and audit adjustments. Escrow accounts established at
the time of purchase  were  funded  with $2.96  million for payment on the notes
payable  and are  included  in other  assets  on the  accompanying  consolidated
balance sheet as of March 31, 1996.

         Effective January 2, 1996, the Company completed the acquisition of the
assets of  Assist-A-Care,  a  pharmacy  located in San  Diego,  California.  The
purchase  price was $5.8  million,  comprised  of $3.2  million  cash and a $2.6
million note payable.

         These  transactions  were  accounted  for using the purchase  method of
accounting under generally accepted accounting principles. Revenues and expenses
are included in the accompanying financial statements subsequent to the purchase
date. The purchase price  allocation  related to these  transactions has not yet
been finalized.

         The following unaudited proforma condensed  consolidated  statements of
earnings  present  the  summarized  consolidated  results of  operations  of the
Company  after  giving  effect to the  acquisitions  of Liberty  and  affiliated
businesses  to Liberty for the three months ended March 31, 1996 and 1995, as if
such acquisitions had been consummated on January 1, 1995 (in thousands,  except
per share data): <TABLE>


<CAPTION>

                                                                            1996                    1995
                                                                            ----                    ----
<S>                                                                           <C>                        <C>    

Net operating revenue                                                       $136,768                  $117,447
Total costs and expenses                                                     131,427                   112,243
- --------------------------------------------------------------------------------------------------------------
Income before provisions for income taxes                                      5,341                     5,204
Provision for income taxes                                                     2,256                     1,982
- --------------------------------------------------------------------------------------------------------------
Net income                                                                  $  3,085                  $  3,222
- --------------------------------------------------------------------------------------------------------------
Income per common share:
     Primary                                                                    $.18                      $.19
     Fully diluted                                                              $.17                      $.18
==============================================================================================================
</TABLE>



         The pro forma results are presented for informational purposes only and
are not necessarily indicative of what results of operations actually would have
been had such  acquisitions  been consummated at the beginning of such period or
of  future  operations  or  results.  The  effect of the  other  acquisition  is
immaterial.

4.       Dispositions

         On March 1, 1996, the Company disposed of a 98-bed facility in Lynwood,
California  resulting  in a net loss of  $182,000  charged  against  the reserve
established in the fourth quarter 1995.

5.       Workers' Compensation Claims Trust

         In 1995,  the Company  established  a revocable  workers'  compensation
claims   payment   trust   ("Trust")  to  pre-fund  its  workers'   compensation
obligations. The Trust was funded in March 1996 with approximately $10.6 million
from  available  cash. At March 31, 1996,  $3.9 million of the amount funded was
classified as current  restricted  cash and $6.7 million was classified as other
long-term assets.

6.       Subsequent Events

         On April 1, 1996, the Company  completed the  acquisition of the assets
of Buena Vista Nursing  Center,  a health care facility with 64 skilled  nursing
beds and 22 assisted  living beds,  located in Lexington,  North  Carolina.  The
purchase  price was $2.875  million,  consisting of $2.675 million in cash and a
$200,000 deferred note.  Payment of the note is dependent upon certain financial
performance targets being achieved.






<PAGE>


Item 2.  Management's Discussion and Analysis of Financial Condition and 
         Results of Operation.

General

         The following  table sets forth certain  operating data for the Company
on the dates indicated:
<TABLE>


 <CAPTION>
                                                                                March 31,
                                                                          1996              1995
<S>                                                                        <C>               <C>   
                                                                          ----              ----
        Long-term care operations...................................
             Facilities.............................................         111                 93
             Licensed beds..........................................      11,455              9,134
             Subacute beds..........................................       1,108                879
             Subacute facilities....................................          46                 35

        Contract rehabilitation therapy operations
             Non-affiliated facilities served.......................          78                 --
             Regency operated facilities served.....................          34                 --
                                                                          ------              -----
                       Total........................................         112                 --
                                                                          ======              =====

        Pharmacy operations
             Non-affiliated facilities served.......................          78
             Regency operated facilities served.....................          53                 34
                                                                          ------               ----
                       Total........................................         131                 39
                                                                          ======                ===

        Home health operations
             Visits per period......................................      74,977             62,015
             Hours per period.......................................     105,879             67,406



</TABLE>

Long-Term Care Operations

         The  Company's  long-term  care  operations  derive  its net  operating
revenue from the performance of routine and ancillary  services at the Company's
facilities.  Revenue from routine  services is comprised of charges for room and
board and basic nursing  services for the care of patients,  including  those in
the Company's subacute  specialty units.  Long-term care operations revenue from
ancillary services is comprised of charges for rehabilitative services, subacute
specialty  services,  and  pharmaceutical  products  and  services  provided  to
patients at the Company's facilities.  The long-term care operations derive most
of its ancillary services revenue from Medicare and HMO eligible patients.

         During  the  fourth  quarter of 1995 the  Company  exchanged  leasehold
interests  in  three  healthcare  facilities  with 360  beds in New  Mexico  for
leasehold  interests  in  four  healthcare  facilities  with  461  beds  in Ohio
previously operated by another company. In October 1995, the Company also opened
a newly  constructed  facility and disposed of one additional  facility that was
not announced in 1994.

         Effective  December 31, 1995,  the Company  determined to dispose of 13
facilities  located in California as part of its strategic plan of  diversifying
from California.  The results of operations of these facilities will continue to
be reflected in the Company's  financial  statements  until the  disposition  is
completed,  which is  expected  in 1996.  Effective  March 1, 1996,  the Company
disposed of one of the thirteen facilities.

         Effective   February  1,  1996,  the  Company  acquired  18  healthcare
facilities  with 2,375 beds, 2  pharmacies  and an enteral  feeding  business in
Tennessee  and  North  Carolina,  accounted  for under  the  purchase  method of
accounting (See Note 3 to the Consolidated Financial Statements).

Ancillary Businesses Operations

         In July 1995, the Company acquired SCRS & Communicology,  Inc. ("SCRS")
accounted  for  under  the  purchase   method  of   accounting.   SCRS  provides
rehabilitation   services  to  Company   operated  and  third  party  healthcare
facilities  in 14 states  in the  West,  Midwest,  and  Southeast.  In the first
quarter  1996,  72% of SCRS  revenues  were derived from  providing  services to
non-affiliated healthcare providers.

         The Company's  pharmacy  operations provide  prescription  services and
basic  pharmaceutical  dispensing programs to Company and third party healthcare
facilities.   During  the  first  quarter  of  1996  and  1995,   66%  and  55%,
respectively,  of revenues from pharmacy  operations were derived from providing
services  to  non-affiliated   healthcare  providers  and  patients  at  Regency
facilities  billed  directly to third-party  payors.  In January and February of
1996, the Company acquired three additional  pharmacy  operations  accounted for
under the purchase method of accounting.

         The  Company's  home  health   operations   provide  skilled   nursing,
rehabilitation  and other services in selected areas in California and Ohio. The
Company has positioned its home healthcare capabilities to serve its facilities'
home health needs.

         The Company's  growth  strategy  includes the selective  acquisition of
both new  facilities  as well as other  service  providers.  The Company  incurs
certain costs and operating inefficiencies in connection with the acquisition of
a new facility  following such acquisition,  relating to the integration of such
facility's  financial  and  administrative  systems,  physical  plant  and other
aspects  of  its  operations  into  those  of  the  Company.  In  addition,  the
introduction of a substantial  portion of the Company's contract  rehabilitation
therapy,  pharmacy  and other  ancillary  services to a new facility may take as
long as 12 months to fully implement. There can be no assurance that each of the
service  providers  the  Company  may acquire  will be  profitable,  or that the
acquisition of new facilities that result in significant  integration  costs and
inefficiencies will not adversely affect the Company's profitability.

         The acquisitions occurring in the first quarter 1996 will be 
collectively referred to as the "1996 Acquisitions."



<PAGE>


Results of Operations

         The following  table sets forth the amounts of certain  elements of net
operating  revenue and the  percentage  of total net  operating  revenue for the
periods presented:
<TABLE>

<CAPTION>
                                                                       Three months ended March 31,
                                                                      1996                         1995
<S>                                                              <C>          <C>             <C>         <C> 
                                                                         (dollars in thousands)
Long term care - basic nursing.............................    $66,547         51%          $57,277        59%
Long term care - subacute and rehabilitation...............     41,544         32            31,326        32
                                                             ---------       -----        ---------      ----
     Subtotal long term care...............................    108,091         83            88,603        91
Home health operations.....................................      8,692          6             6,913         7
Contract rehabilitation therapy operations to
     non-affiliates (1)....................................      7,463          6                --       --
Pharmacy operations to non-affiliates (2)..................      4,726          4             1,532         2
Interest...................................................        990          1               500         0
                                                             ---------       -----        ---------      ----
     Total.................................................   $129,962        100%         $ 97,548       100%
                                                              ========        ====         ========       ====

(1)      Net of intercompany billings of $2,928,000 for the three months ended March 31, 1996.
(2)      Net of intercompany billings of $2,472,000 and $1,252,000 for the three months ended March 31, 1996 and 1995, respectively.
</TABLE>


         The following  table presents the  percentage of net operating  revenue
represented by certain items reflected in the Company's Consolidated  Statements
of Operations for the three months ended March 31: <TABLE>






<S>                                                                           <C>           <C>
                                                                              1996          1995


         Net operating revenue...........................................    100.0%        100.0%
                                                                             ------        ------
         Costs and expenses:
         Operating expenses..............................................     82.3          81.0
         Corporate general and administrative............................      4.0           5.4
         Rent expense....................................................      4.3           4.2
         Depreciation and amortization...................................      2.4           2.3
         Interest expense................................................      3.3           2.0
                                                                             -----         -----

             Total costs and expenses....................................     96.3          94.9
                                                                             -----         -----

         Income before provision for income taxes  ......................      3.7%          5.1%
                                                                             ======        ======




</TABLE>

<PAGE>


Quarter Ended Comparison 1996 to 1995

Net Operating Revenue

     The Company's  net  operating  revenue for the three months ended March 31,
1996 ("First Quarter 1996") was $130.0 million compared to $97.5 million for the
three months ended March 31, 1995 ("First Quarter  1995"),  an increase of $32.5
million or 33.2%.

     Net  operating  revenue from  long-term  care  operations  increased  $19.5
million or 22.0% due to the 1996  acquisition of 18 long-term  care  facilities,
increased  levels of  reimbursement,  and a shift in payor mix from  Medicaid to
Medicare  and  managed  care,  partially  offset by a slight  decrease  in total
patient  days on a same  store  basis.  Net  operating  revenue  from  the  1996
acquisition  of 18 long-term  care  facilities  for First Quarter 1996 was $12.6
million.  On a same store basis, the average increase in reimbursement rates per
patient  day was 8.1% and was  primarily  due to  providing  services  to higher
acuity  patients.  The Company  experienced a 0.3% net decrease in total patient
days in First  Quarter  1996 from  First  Quarter  1995 on a same  store  basis,
consisting  of a decrease of 8,114 and 6,781 from Medicaid and private and other
sources,  respectively,  and an  increase of 5,379 and 7,614 from  Medicare  and
managed care, respectively.

      Net  operating  revenue from home health  operations  grew $1.8 million or
25.7% in First  Quarter  1996 over  First  Quarter  1995,  primarily  reflecting
additional  patient visits and treatment  hours.  Pharmacy  operations  revenues
increased  $3.2 million or 208.5% in First Quarter 1996 over First Quarter 1995,
primarily due to the acquisition of  Assist-A-Care in January 1996 and Executive
Pharmacy in February  1996  (collectively,  the  "Pharmacy  Acquisitions").  Net
operating revenue from the Pharmacy Acquisitions for First Quarter 1996 was $2.7
million. Net operating revenue from contract  rehabilitation  therapy operations
are a result  of the  purchase  of SCRS in July  1995.  The  Company  had no net
operating revenue from contract  rehabilitation  therapy operations in the First
Quarter 1995.

     Interest  income  increased  $0.5 million in First  Quarter 1996 over First
Quarter  1995 due to  investment  of  proceeds  from the  issuance of the 9-7/8%
Senior Subordinated Notes ("Subordinated  Notes") in an aggregate amount of $110
million in October 1995.

Costs and Expenses

     Total costs and expenses for First Quarter 1996 increased $32.6 million, or
35.3%,  to $125.2  million  (96.3% of net operating  revenue) from $92.6 million
(94.9% of net operating revenue) for First Quarter 1995.

     Operating  expenses as a percentage of net operating  revenue  increased to
82.3% for First Quarter 1996, from 81.0% for First Quarter 1995. The increase is
a result of  incurring  increased  labor  costs  while  reimbursement  rates per
patient day for room and board charges  remained  relatively  flat. In addition,
the home health  agency  participating  in the Medicare  Prospective  Pay System
pilot project beginning in 1996 did not adequately reduce costs at the outset of
this program.

     Corporate general and administrative  expense is the corporate overhead and
regional costs related to the supervision of operations.  This expense decreased
as a percentage  of net  operating  revenue to 4.0% for First  Quarter 1996 from
5.4% in First  Quarter  1995.  The  decrease  as a  percentage  of  revenues  is
attributed to achieving  economies of scale through  acquisition  and same store
growth.

     Depreciation  and  amortization  expense as a percentage  of net  operating
revenue  increased to 2.4% in First Quarter 1996 from 2.3% in First Quarter 1995
primarily due to goodwill  amortization  related to the purchase of SCRS in July
1995 and Liberty in February 1996.

     Interest expense as a percentage of net operating revenue increased to 3.3%
in First  Quarter  1996 from 2.0% in First  Quarter  1995  primarily  due to the
Company issuing the Subordinated  Notes partially offset by the repayment of the
Senior Secured Notes in October 1995.

Liquidity and Capital Resources

     Working  capital at March 31, 1996 decreased $51.0 million to $68.3 million
(including  cash and cash  equivalents  of $34.0  million)  from $119.3  million
(including  cash and cash  equivalents of $104.2  million) at December 31, 1995.
The decrease was primarily  attributable  to the 1996  Acquisitions.  During the
First Quarter 1996, the Company funded  approximately $16 million in receivables
primarily  related to the deferral of Medicare and Medicaid  billings  until the
second quarter 1996 caused by delays in securing provider numbers for certain of
the 18 healthcare facilities acquired in the 1996 Acquisitions. In addition, the
Company  established a revocable workers'  compensation  claims payment trust to
pre-fund its workers'  compensation  obligations  which was funded in March 1996
with approximately $10.6 million from available cash. Of the amount funded, $3.9
million is classified as current  restricted cash and $6.7 million is classified
as other long-term  assets as of March 31, 1996 (See Note 5 to the  Consolidated
Financial Statements).

     The Company's major  requirements  for liquidity  relate to funding working
capital,  capital  improvements and debt service  obligations.  The Company must
also  provide  funding  to  cover  potential  delays,  temporary  cessations  or
interruption  in payments by  third-party  payors due to  political or budgetary
constraints.  Management  believes  that these  liquidity  needs can be met from
available cash, internally generated funds and existing borrowing capacity under
the NationsBank credit agreement (discussed below).

     The  Company's  capital  expenditures  for the three months ended March 31,
1996 and 1995 were  approximately  $2.6 million and $4.1 million,  respectively.
These  capital   expenditures  have  been  financed  through  a  combination  of
internally  generated funds and debt. The Company expects to spend approximately
$13.0 million for capital  expenditures  during 1996.  The Company's  healthcare
facilities  require capital  improvements  for  renovations and  improvements in
physical  appearance.  In addition,  capital improvements may be required in the
future as a result of routine regulatory inspections.

     The Company has financed its acquisitions  from a combination of borrowings
and funds  generated  by  operations.  The  Company  expects to  finance  future
acquisitions  from a  combination  of  existing  cash,  the  NationsBank  credit
facility,  and  alternative  sources  such as  real  estate  investment  trusts.
Depending on the numbers, size and timing of any such transactions,  the Company
may in the future  require  additional  financing  in order to  continue to make
acquisitions.

     Periodically, the Company has funded temporary delays in reimbursement from
third-party payors. For example,  in July 1995, the State of California,  due to
budgetary constraints, delayed payment of significant amounts owed to healthcare
providers  under  the  Medi-Cal  program.  In  1992,  the  State  of  California
reimbursed  providers with  registered  warrants,  which some banks  temporarily
refused to redeem at face  value.  The  Company  has been able to  mitigate  the
effects of such  payment  delays by  monitoring  the related  activities  of the
California legislature, expediting billings through its direct access electronic
billing arrangement,  and obtaining the agreement of creditors to extend the due
date for payables. The Company has not recently experienced any material adverse
effects on its liquidity as a result of such delays.  There can be no assurance,
however,  that the Company  will be able to  mitigate  the effects of any future
funding delays by the State of California or other third-party payors.

     On  December  28,  1995 the Company  entered  into a revolving  credit loan
agreement  ("Credit  Agreement") with NationsBank of Texas,  N.A. as agent for a
group of banks,  which  provides up to $50,000,000 in a revolving line of credit
and letters of credit.  As of April 30, 1996, no  borrowings  have been drawn on
the Credit Agreement and  approximately  $9,000,000 of standby letters of credit
have  been  issued  in  connection  with  the  Company's  self-insured  workers'
compensation programs. Seasonality

     The  Company's  income  from  operations  before  fixed  charges  generally
fluctuates  from  quarter  to  quarter.  The  fluctuation  is related to several
factors: the timing of Medicaid rate increases,  seasonal census cycles, and the
number of calendar days in a given quarter.  As a result,  the Company's  income
from operations  before fixed charges tends to be higher in its third and fourth
quarters when compared to the first and second quarters.

Impact of Inflation

     The healthcare industry is labor intensive. Wages and other labor costs are
especially sensitive to inflation. Increases in wages and other labor costs as a
result of  inflation,  or increases in federal or state  minimum wages without a
corresponding  increase in Medicare  and  Medicaid  reimbursement  rates,  could
adversely impact the Company.

Reimbursement

     The  majority  of the  Company's  net  operating  revenue is  derived  from
services provided under the Medicare and Medicaid  programs.  Numerous proposals
relating  to  healthcare  reform  have been or may be  introduced  in the United
States Congress, state legislatures or by governmental agencies who regulate the
Medicare and Medicaid  programs.  It is uncertain what reform will ultimately be
enacted by the federal government, any state government or governmental agencies
and therefore, the Company cannot predict at this time the impact on the Company
of any proposed reforms.

     As  discussed  above,  the Company  provides  contract  rehabilitation  and
pharmacy services to both Regency operated and non-affiliated facilities.  Under
current  Medicare  regulations,  reimbursement  for these  services  provided to
Medicare  eligible  patients  in Regency  facilities  is based upon the  related
entity's  cost to  provide  the  services  unless a  significant  portion of the
related  entity's  revenues  is derived  from  non-affiliated  facilities.  If a
significant   portion  of  the  related   entity's   revenues  is  derived  from
non-affiliated  facilities,  Medicare will reimburse the facility's  cost, which
includes a profit paid to the related entity.  During 1995 and prior years,  the
Company was  reimbursed  by Medicare  based on its pharmacy  operation  costs on
billings  to  Regency  facilities,  as it did not meet the  significant  portion
criteria. After the acquisition of Assist-A-Care Pharmacy and Executive Pharmacy
in 1996, the Company  believes it meets the "significant  portion"  criteria and
began recording a profit on billings for pharmacy  services provided to Medicare
eligible  patients  in Regency  facilities.  The  Company  believes it meets the
"significant   portion"  criteria  for  its  contract   rehabilitation   therapy
operations  provided by SCRS, and therefore has recorded a profit on billings to
Regency  facilities since the acquisition of SCRS.  Medicare  regulations do not
define  a  "significant  portion,"  therefore,   the  Company's  and  Medicare's
interpretations  could  differ,  which could result in  retroactive  adjustments
related to the  profit on  billings  to  Regency  facilities  for  pharmacy  and
contract rehabilitation services.

     In the recently  enacted  federal budget deficit  reduction  bill,  various
reimbursement  rules and regulations were adopted by the federal government that
pertain  to  the  Company.   The  recently   effective  changes  to  regulations
promulgated  under OBRA, some of which expand the remedies  available to enforce
regulations mandating minimum healthcare  standards,  may have an adverse effect
on the  Company's  operations.  The Company is unable to predict the  particular
effect on the Company until the manner in which these regulations is implemented
becomes known.







<PAGE>


Part II. Other Information

Item 1. Legal Proceedings.

         None

Item 6. Exhibits and Reports on Form 8-K.

1)       The Company  filed a current  report on Form 8-K,  dated  February  15,
         1996,  which  reported  under Item 2 the  acquisition of (i) 18 skilled
         long-term care facilities from Liberty Healthcare Limited  Partnership,
         (ii) an enteral  feeding  business from Liberty  Assisted Living Center
         Limited Partnership, and (iii) Executive Pharmacy Services, Inc.
         effective February 1, 1996.

2)       The Company filed a Current Report on Form 8-K/A, dated April 12, 1996,
         which  amended  the Form 8-K dated  February  15,  1996,  and  provided
         financial statements and exhibits required under Item 7.

<PAGE>


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


REGENCY HEALTH SERVICES, INC.


         BRUCE D. BROUSSARD
By:_____________________________________________________
         Bruce D. Broussard
         Executive Vice President and Chief Financial Officer

Date:    June 24, 1996


<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>               1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-1-1996
<PERIOD-END>                                   MAR-31-1996
<CASH>                                         33,955
<SECURITIES>                                   0
<RECEIVABLES>                                  75,759
<ALLOWANCES>                                   4,259
<INVENTORY>                                    0
<CURRENT-ASSETS>                               132,600
<PP&E>                                         167,064
<DEPRECIATION>                                 36,965
<TOTAL-ASSETS>                                 354,306
<CURRENT-LIABILITIES>                          64,348
<BONDS>                                        184,148
                          0
                                    0
<COMMON>                                       167
<OTHER-SE>                                     83,292
<TOTAL-LIABILITY-AND-EQUITY>                   354,306
<SALES>                                        0
<TOTAL-REVENUES>                               129,962
<CGS>                                          0
<TOTAL-COSTS>                                  106,967
<OTHER-EXPENSES>                               8,782
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             4,327
<INCOME-PRETAX>                                4,760
<INCOME-TAX>                                   2,023
<INCOME-CONTINUING>                            2,737
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   2,737
<EPS-PRIMARY>                                  .16
<EPS-DILUTED>                                  .16
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission